282
A. Moscardini et al. / Journal of Molecular Liquids 277 (2019) 280–289
ether (3 × 50 mL) and then concentrated under reduced pressure to
2.3.2.
N,N,N′,N′ tetramethyl N″,N″ butylethylguanidinium
bis
give the final product.
(trifluoromethylsulfonyl) imide (2)
Clear liquid 0,916 g, yield 95%; 1H NMR (DMSO) δ 3.41–3.07 (m, 4H),
2.94–2.91 (d, 12H), 1.67–1.37 (m, 2H), 1.36–1.20 (m, 2H), 1.17 (t, J =
7.1 Hz, 3H), 0.91 (t, J = 7.2 Hz, 3H) ppm. 13C NMR (DMSO) δ 162.3,
126.7–111.3, 47.8, 43.4, 39.3, 39.2, 28.5, 19.0, 12.6, 12.0 ppm. IR (ATR):
ν = 2963 (b), 2938 (b), 2879 (b), 2816 (m), 1565 (i), 1411 (m), 1348
2.2.1. N,N,N′,N′ tetramethyl N″,N″ butylmethylguanidinium chloride (1a)
White solid 9,83 g, yield 89%; 1H NMR (CDCl3) δ 3.15 (t, J = 7.6 Hz,
2H), 3.07 (s, 3H), 3.00 (s, 6H), 2.97 (s, 6H), 1.50 (m, 2H), 1.34–1.07
(m, 2H), 0.85 (t, J = 7.2 Hz, 3H) ppm. 13C NMR (CDCl3) δ 163.4, 52.5,
40.8, 40.46, 38.3, 29.6, 19.9, 13.7 ppm. IR (ATR): ν = 2956 (m), 2931
(i), 1177 (i), 1135 (i), 1054 (i) cm−1
.
(m), 2872 (m), 1576 (i), 1468 (b), 1403 (i), 1254 (b) cm−1
.
2.3.3. N,N,N′,N′ tetramethyl N″,N″ pentamethyleneguanidinium bis
(trifluoromethylsulfonyl) imide (3)
2.2.2. N,N,N′,N′ tetramethyl N″,N″ butylethylguanidinium chloride (2a)
White solid 9,43 g, yield 80%; 1H NMR (DMSO) δ 2.86–2.65 (m, 4H),
2.53 (s, 12H), 1.10 (bs, 2H), 0.94–0.76 (m, 2H), 0.71 (t, J = 7.1 Hz, 3H),
0.48 (t, J = 7.2 Hz, 3H) ppm. 13C NMR (DMSO) δ 162.0, 47.7, 43.6, 38.7,
28.0, 18.9, 12.5, 10.9 ppm.
Clear liquid 0,910 g, yield 96%; 1H NMR (CDCl3) δ 3.22 (bm, 4H),
2.94–2.92 (d, 12H), 1.67 (s, 6H) ppm. 13C NMR (CDCl3) δ 162.8,
127.7–111.6, 49.9, 40.2, 40.2, 25.1, 23.4 ppm. IR (ATR): ν = 2944 (b),
2864 (b), 1619 (i), 1563 (i), 1416 (b), 1348 (i), 1175 (i), 1134 (i),
1052 (i) cm−1
.
2.3.4.
N,N,N′,N′ tetramethyl N″,N″ esamethyleneguanidinium
bis
2.2.3. N,N,N′,N′ tetramethyl N″,N″ pentamethyleneguanidinium chloride
(3a)
(trifluoromethylsulfonyl) imide (4)
Light yellow clear liquid 0,930 g, yield 95%; 1H NMR (CDCl3) δ 3.32
(s, 4H), 2.89 (s, 12H), 1.66 (bm, 8H) ppm. 13C NMR (CDCl3) δ 163.3,
128.1–117.8, 52.1, 40.3, 40.1, 29.5, 26.4 ppm. IR (ATR): ν = 2936 (b),
2863 (b), 1588 (m), 1562 (i), 1410 (m), 1347 (i), 1175 (i), 1134 (i),
White solid 8,27 g, yield 75%; 1H NMR (CDCl3) δ 3.18 (m, 4H), 2.83 (s,
6H), 2.81 (s, 6H), 1.57 (bs, 6H) ppm. 13C NMR (CDCl3) δ 162.8, 50.1, 41.0,
40.8, 25.3, 22.5 ppm. IR (ATR): ν = 2930 (m), 2856 (m), 1564 (i), 1435
(m), 1407 (i), 1277 (b), 1253 (b) cm−1
.
1053 (i) cm−1
.
2.2.4. N,N,N′,N′ tetramethyl N″,N″ esamethyleneguanidinium chloride (4a)
White solid 8,97 g, yield 77%; 1H NMR (CDCl3) δ 3.28 (bs, 4H), 2.94
(s, 6H), 2.89 (s, 6H), 1.44 (bm, 8H) ppm. 13C NMR (CDCl3) δ 163.1,
52.0, 40.6, 29.1, 26.5 ppm. IR (ATR): ν = 2912 (m), 2852 (m), 1579
2.3.5.
1 (1,3 Dimethylimidazolidin 2 yliden)
piperidinium
bis
(trifluoromethylsulfonyl) imide (5)
Yellow clear liquid 0,907 g, yield 96%; 1H NMR (DMSO) δ 3.14 (bs,
4H), 2.82 (bs, 4H), 2.43 (bs, 6H), 1.13 (bs, 6H) ppm. 13C NMR (DMSO)
δ 162.1, 126.6–111.3, 48.3, 48.1, 34.6, 24.5, 22.0 ppm. IR (ATR): ν =
2947 (b), 2864 (b), 1619 (i), 1563 (i), 1416 (b), 1348 (i), 1175 (i),
(i), 1479 (b), 1449 (b), 1408 (i), 1299 (b), 1233 (b) cm−1
.
1134 (i), 1052 (i) cm−1
.
2.2.5. 1 (1,3 Dimethylimidazolidin 2 yliden) piperidinium chloride (5a)
Amber clear oil 5,27 g, yield 48%; 1H NMR (CDCl3) δ 3.64 (s, 4H), 3.18
(bs, 4H), 2.86 (s, 3H), 2.86 (s, 3H), 1.45 (bs, 6H) ppm. 13C NMR (63 MHz,
CDCl3) δ 162.7, 49.5, 49.4, 36.4, 25.5, 22.8 ppm. IR (ATR): ν = 2937 (m),
2.3.6.
1 (1,3 Dimethylimidazolidin 2 yliden)
azepanium
bis
(trifluoromethylsulfonyl) imide (6)
Light yellow clear liquid 0,897 g, yield 92%; 1H NMR (CDCl3) δ 3.64
(bs, 4H), 3.45–3.33 (m, 4H), 2.91 (s, 6H), 1.68 (sm, 4H), 1.65–1.52
(sm, 4H) ppm. 13C NMR (CDCl3) δ 164.2, 127.4, 122.3, 117.2, 112.0,
52.0, 49.4, 36.4, 28.4, 27.4 ppm. IR (ATR): ν = 2938 (b), 2863 (b),
2857 (m), 1615 (i), 1557 (i), 1447 (b), 1414 (b), 1303 (i) cm−1
.
2.2.6. 1 (1,3 Dimethylimidazolidin 2 ylidene) azepanium chloride (6a)
Amber clear oil 5,01 g, yield 43%; 1H NMR (CDCl3) δ 3.73 (bs, 4H),
3.46–3.40 (m, 4H), 2.99 (s, 6H), 1.72–1.60 (s, 4H), 1.58–1.53 (m, 4H)
ppm. 13C NMR (CDCl3) δ 164.4, 52.3, 50.1, 37.2, 28.4, 27.9 ppm. IR
(ATR): ν = 2925 (m), 2856 (m), 1602 (i), 1556 (i), 1452 (b), 1413
1604 (i), 1562 (m), 1416 (b), 1348 (i), 1174 (i), 1134 (i), 1052 (i) cm−1
.
3. Results and discussion
(b), 1305 (m), 1299 (b), 1233 (b) cm−1
.
3.1. Synthesis and conformational analysis
A well-known procedure has been followed to prepare the six
guanidinium ILs (Fig. 1, top) [16]. Briefly, a commercial urea (either
tetramethyl urea or N,N′ dimethylethylene urea) was reacted with
oxalyl chloride to afford the corresponding chloroformamidinium chlo-
ride which was then treated with a secondary amine. The obtained
guanidinium chloride IL was converted into the corresponding
bistriflimide IL through a metathesis reaction with LiTf2N. The struc-
tures of the ILs 1–6 are summarized in Fig. 1 (bottom). It is worth men-
tioning that a drop in yield was observed in the first step for the cyclic
urea, from 75–80% (1–4) to 43–48% (5,6).
2.3. General procedure for the preparation of hexaalkyl guanidinium
bistriflimide
A solution of lithium bis(trifuoromethylsulfonyl)imide (0,59 g,
2 mmol) in water (5 mL) was added dropwise to a solution of
hexaalkylguanidinium chloride (2 mmol) in water (6 mL). The resulting
solution was stirred at room temperature for 3 h and then 30 mL of di-
chloromethane were added. The organic phase was separated and
washed with several portions of deionised water until chloride could
not be detected (AgNO3 test). The organic phase was dried over
Na2SO4, filtered, and the solvent was removed under reduced pressure.
The obtained product was analyzed by NMR and FTIR.
The identity of the obtained compounds has been ascertained by
means of NMR and IR analyses. IR spectra displayed the distinctive ab-
sorption band for the CN3+ at around 1561–1578 cm−1
.
As reported before for other guanidinium ILs [32], a split for the
methyl signals of compound 1–4 was observed in the 13C NMR spectra.
These were performed in co-axial tubes with DMSO d6 in the internal
capillary as a lock and chemical shift reference. The observed phenome-
non arises from the C-NR2 partial double bond character which hinders
the free rotation and thus renders the otherwise magnetically equivalent
symmetrical substituents on the nitrogen atoms magnetically non-
equivalent. By heating at 70 °C, the rotation barriers were overcome,
2.3.1.
N,N,N′,N′ tetramethyl N″,N″ butylmethylguanidinium
bis
(trifluoromethylsulfonyl) imide (1)
Light yellow clear liquid 0,903 g, yield 95%; 1H NMR (CDCl3) δ 3.12 (t,
J = 7.6 Hz, 2H), 2.91 (s, 12H), 2.88 (s, 3H), 1.55 (bs, 2H), 1.38–1.19 (m,
2H), 0.90 (t, J = 7.3 Hz, 3H) ppm. 13C NMR (CDCl3) δ 163.4, 128.1–112.4,
52.5, 40.1, 37.7, 29.5, 19.8, 13.5 ppm. IR (ATR): ν = 2963 (b), 2878 (b),
1578 (i), 1409 (m), 1348 (i), 1176 (i), 1134 (i), 1053 (i) cm−1
.